Results 201 to 210 of about 38,746 (286)

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan   +2 more
wiley   +1 more source

Exploring the Association Between Mental Disorders and Various Arrhythmias via Mendelian Randomization Methods

open access: yesGenes, Brain and Behavior, Volume 25, Issue 3, June 2026.
Based on the validity of instrumental variable assumptions, our Mendelian randomization analysis revealed that genetic predisposition to major depression was associated with an increased risk of arrhythmias and suggested potential bidirectional effects between major depression and atrioventricular block. ABSTRACT Major depression, bipolar disorder, and
Jingyang Su   +3 more
wiley   +1 more source

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

open access: yesHepatology Research, Volume 56, Issue 6, Page 887-902, June 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, with an increasing number of patients progressing to cirrhosis and hepatocellular carcinoma (HCC). Early identification of individuals at high risk for advanced fibrosis is essential for preventing liver‐related ...
Norio Akuta   +44 more
wiley   +1 more source

Spatial and temporal dispersion of ventricular repolarization in pediatric patients with congenital long QT syndrome. [PDF]

open access: yesHeartRhythm Case Rep
Dai L   +7 more
europepmc   +1 more source

Kidney supportive care in Australia and New Zealand: an Australian and New Zealand Society of Nephrology (ANZSN) and Australian and New Zealand Society of Palliative Medicine (ANZSPM) guidance document

open access: yesInternal Medicine Journal, Volume 56, Issue S2, Page 4-48, June 2026.
The purpose of this document is to provide a summary of the current expert opinion and recent literature for clinicians, Indigenous health workers and patient advocates interested in Kidney Supportive Care (KSC) in Australia and New Zealand. Our purpose is not to duplicate the recently released International Society of Nephrology (ISN) KSC/Conservative
Kathryn Ducharlet   +23 more
wiley   +1 more source

Disparities in Advance Care Planning: Did COVID‐19 Change Anything?

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 6, Page 1722-1728, June 2026.
ABSTRACT Background Rates of advance care planning (ACP) are lower and preferences for life‐prolonging treatment are higher among Black compared to White older adults. We examined whether these differences persisted during the COVID‐19 pandemic. Methods Between February 2021 and September 2022, we conducted a cross‐sectional COVID‐19–focused survey of ...
Anupama Gangavati   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy